Sarcopenia is the decline in skeletal muscle mass associated with decreased strength and/or function which commonly occurs as a result of age, reduced muscle activity or certain comorbid conditions (for more info, click here). While there is not agreed upon diagnostic criteria for sarcopenia in the United States, a variety of different methods have been suggested and used to screen for muscle loss, strength, and function (for more info, click here).
During the planning phase, NUCOAT researched six conditions that commonly occur with sarcopenia. The original plan was to narrow down to three conditions associated with sarcopenia to further investigate during the research phase; however, the NUCOAT team and FDA agreed that understanding sarcopenia in older adults would be more valuable to understand physical function limitations rather than to narrow it into sarcopenia in specific diseases.